Axogen, Inc. (AXGN) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Axogen, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a0422f-4a52-7660-bdc8-c4f95fb368f7 Created: 2026-08-27T07:46:32.752Z Duration: 3156.689 Channels: 1 00:00:00.080 -- 00:00:01.119 Good morning, everyone. 00:00:01.680 -- 00:00:03.760 Joining me on today's call is Michael Dale, 00:00:03.760 -- 00:00:06.799 Axogen's President and Chief Executive Officer and Lindsay 00:00:06.799 -- 00:00:08.559 Hartley, Chief Financial Officer. 00:00:08.960 -- 00:00:11.519 Michael will discuss second quarter twenty twenty six 00:00:11.679 -- 00:00:13.215 results and corporate highlights. 00:00:13.535 -- 00:00:16.095 Lindsay will then provide details on financial performance 00:00:16.095 -- 00:00:18.655 and overall outlook for the year. This will 00:00:18.655 -- 00:00:20.654 be followed by a question and answer session. 00:00:24.015 -- 00:00:26.095 Call and presentation is being broadcast live via 00:00:26.095 -- 00:00:28.440 webcast, which is available on the Investors section 00:00:28.440 -- 00:00:29.880 of Axogen's website. 00:00:30.360 -- 00:00:32.040 Following the end of the live call, a 00:00:32.040 -- 00:00:34.280 replay will be available on the Investors section 00:00:34.280 -- 00:00:39.480 of the company's website at www.axogeninc.com. 00:00:41.395 -- 00:00:43.155 Before we begin, I would like to remind 00:00:43.155 -- 00:00:45.555 you that during this conference call, management will 00:00:45.555 -- 00:00:47.315 be making forward looking statements. 00:00:47.795 -- 00:00:50.675 Forward looking statements include statements regarding financial guidance 00:00:50.675 -- 00:00:51.555 and outlook, 00:00:51.635 -- 00:00:53.715 clinical development and regulatory efforts, 00:00:54.390 -- 00:00:56.390 commercial growth initiatives, 00:00:56.390 -- 00:00:58.390 reimbursement an...